Feature|Articles|August 20, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
2025 Emerging Pharma Leaders
Author(s)Mike Hollan
Listen
0:00 / 0:00
Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives steering innovative scientific and strategic pursuits in R&D, market access, and patient support.
Advertisement
Follow the links below to read about each selection:
(In alphabetical order)
*These five individuals were chosen from a pool of nominations by the Pharmaceutical Executive Editorial staff. Selections were based on a number of criteria and review of professional accomplishments and progression of responsibilities in line with those executives inhabiting key “c-suite” functions.
Articles in this issue
3 months ago
The CAR-T Climb3 months ago
An RNA-Guided Path3 months ago
Acceleration and Ambition3 months ago
Driving Disruption in Delivery3 months ago
Building Promise from Precision3 months ago
Determined Problem-Solver3 months ago
How to Get Product Iteration Right in HealthcareNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
5
